Meeting Highlight View All

Shaping romosozumab treatment for postmenopausal osteoporosis: Balancing the fracture benefit and cardiovascular risk

05 May 2021

Professor Gaetano De Ferrari

Full Professor of Cardiology,
University of Torino,
Head of Cardiology, Città della Salute,
Torino, Italy

Research spotlight View All

Exploring the association of systemic glucocorticoids and incident major adverse cardiovascular events in patients with rheumatoid arthritis based on real-world data

Despite their exceptional anti-inflammatory properties, the use of systemic glucocorticoids (GCs) for the treatment of rheumatoid arthritis (RA) remains controversial due to the potential side effects, particularly their role in elevating patients’ risk of cardiovascular (CV) events. A po

03 Jan 2024

Dr. So, Ho

Assistant Professor,
Division of Rheumatology,
Department of Medicine and Therapeutics,
Faculty of Medicine,
The Chinese University of Hong Kong

Ann Rheum Dis. 2023.

So H, Lam TO (co-first author), Meng H, Lam SHM, Tam LS. Time and dose-dependent effect of systemic glucocorticoids on major adverse cardiovascular event in patients with rheumatoid arthritis: a population-based study. Ann Rheum Dis. 2023;82(11):1387-1393.